EUVIMEDEUVIMED entdecken
Crossref

“Golgi-customized Trojan horse” nanodiamonds impair GLUT1 plasma membrane localization and inhibit tumor glycolysis

Bei Kang, Haobo Wang, Huaqing Jing, Yunsheng Dou, Sona Krizkova, Zbynek Heger, Vojtech Adam, Nan Li

Journal of Controlled Release · 2024

DOI: 10.1016/j.jconrel.2024.05.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Bei Kang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China. Hauptthemen laut MEDLINE: Glycolysis, Golgi Apparatus, Cell Membrane, Glucose Transporter Type 1. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Young Elite Scientists Sponsorship Program by Tianjin, National Natural Science Foundation of China, Grantová Agentura České Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nutrient or energy deprivation, especially glucose restriction, is a promising anticancer therapeutic approach. However, establishing a precise and potent deprivation strategy remains a formidable task. The Golgi morphology is crucial in maintaining the function of transport proteins (such as GLUT1) driving glycolysis. Thus, in this study, we present a "Golgi-customized Trojan horse" based on tellurium loaded with apigenin (4',5,7-trihydroxyflavone) and human serum albumin, which was able to induce GLUT1 plasma membrane localization disturbance via Golgi dispersal leading to the inhibition of tumor glycolysis. Diamond-shaped delivery system can efficiently penetrate into cells as a gift like Trojan horse, which decomposes into tellurite induced by intrinsically high H2O2 and GSH levels. Consequently, tellurite acts as released warriors causing up to 3.8-fold increase in Golgi apparatus area due to the down-regulation of GOLPH3. Further, this affects GLUT1 membrane localization and glucose transport disturbance. Simultaneously, apigenin hinders ongoing glycolysis and causes significant decrease in ATP level. Collectively, our "Golgi-customized Trojan horse" demonstrates a potent antitumor activity because of its capability to deprive energy resources of cancer cells. This study not only expands the applications of tellurium-based nanomaterials in the biomedicine but also provides insights into glycolysis restriction for anticancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycolysisGolgi ApparatusCell MembraneGlucose Transporter Type 1ApigeninTelluriumHumansCell Line, TumorNeoplasmsAnimalsAntineoplastic AgentsGlucose

Stichwörter der Autor:innen

ApigeninGLUT1 disturbanceGlycolysis inhibitionGolgi dispersalTellurite

Substanzen

Glucose Transporter Type 1ApigeninSLC2A1 protein, humanTelluriumAntineoplastic AgentsGlucose

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China.
  • Department of Chemistry and Biochemistry, Mendel University in Brno, CZ-61300 Brno, Czech Republic.
  • Tianjin Key Laboratory of Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China. Electronic address: linan1985@tju.edu.cn.

Förderung

  • Young Elite Scientists Sponsorship Program by Tianjin
  • National Natural Science Foundation of China
  • Grantová Agentura České Republiky
  • National Key Research and Development Program of China

Zitieren

APA

Kang, B., Wang, H., Jing, H., Dou, Y., Krizkova, S., Heger, Z., Adam, V., & Li, N. (2024). “Golgi-customized Trojan horse” nanodiamonds impair GLUT1 plasma membrane localization and inhibit tumor glycolysis. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.05.025

Vancouver

Kang B, Wang H, Jing H, Dou Y, Krizkova S, Heger Z, et al. “Golgi-customized Trojan horse” nanodiamonds impair GLUT1 plasma membrane localization and inhibit tumor glycolysis. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2024.05.025

BibTeX
@article{Kang2024,
  author = {Kang, Bei and Wang, Haobo and Jing, Huaqing and Dou, Yunsheng and Krizkova, Sona and Heger, Zbynek and Adam, Vojtech and Li, Nan},
  title = {“Golgi-customized Trojan horse” nanodiamonds impair GLUT1 plasma membrane localization and inhibit tumor glycolysis},
  journal = {Journal of Controlled Release},
  year = {2024},
  doi = {10.1016/j.jconrel.2024.05.025}
}
Kostenlos starten →